생물정신의학 (Korean Journal of Biological Psychiatry)
- 제4권1호
- /
- Pages.116-120
- /
- 1997
- /
- 1225-8709(pISSN)
- /
- 2005-7571(eISSN)
항우울제와 우울증 환자의 삶의 질 - 삼환계 항우울제와 Sertraline을 중심으로 -
Antidepressant and the Quality of Life of Depressive Patient
- Ham, Byung-Joo (Department of Neuropsychiatry, College of Medicine, Korea University) ;
- Lee, Min-Soo (Department of Neuropsychiatry, College of Medicine, Korea University)
- 발행 : 1997.06.25
초록
This study investigated the antidepressant efficacy and it's impact on the quality of life of depressed patients. We performed Hamilton Depression Rating Scale(HDRS), and Montgomery-Asberg Depression Rating Scale(MADRS), and Health-related Quality of Life Questionnaire(HQLQ) to both tricyclic antidepressant(TCA) and sertraline groups. There were 16 subjects in this study. The tricyclic group had 9 subjects and the sertraline group had 7. The TCA and sertraline produced a similar degree of response. Both groups experienced a reduction of 70% or more in mean HDRS and MADRS total score after 6wks. In HQLQ, the TCAs group also showed improved bed disability days, alertness behavior, and social interaction, the sertraline group showed improved health perception, alertness behavior, home management, and social interaction. We suggested that the improvement of "Quality of life" were not in proportion to the clinical symptom's improvement. Therefore, clinicians should consider the benefit of antidepressant treatment in terms of quality of life.